Eli Lilly EPS - Earnings per Share 2012-2026 | LLY

Eli Lilly earnings per share (EPS) for the twelve months ending March 31, 2026 was $28.15, a 129.05% increase year-over-year.

  • Eli Lilly EPS for the quarter ending March 31, 2026 was $8.26, a 169.93% increase year-over-year.
  • Eli Lilly 2025 annual EPS was $22.95, a 95.99% increase from 2024.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Eli Lilly EPS - Earnings per Share 2012-2026 | LLY

  • Eli Lilly EPS for the quarter ending March 31, 2026 was $8.26, a 169.93% increase year-over-year.
  • Eli Lilly 2025 annual EPS was $22.95, a 95.99% increase from 2024.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B